Northern Trust
ALGS icon

Northern Trust’s Aligos Therapeutics ALGS Stock Holding History

Northern Trust’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,157
Closed -$205K – 4420
2024
Q4 		$205K Buy
+5,157
New +$99.7K ﹤0.01% 3983
2024
Q3 		– Sell
-3,678
Closed -$32.2K – 4413
2024
Q2 		$32.2K Sell
3,678
-3
-0.1% -$53 ﹤0.01% 4276
2024
Q1 		$90.2K Buy
3,681
+1,522
+70% +$30.3K ﹤0.01% 4105
2023
Q4 		$35.8K Buy
2,159
+585
+37% +$10.1K ﹤0.01% 4292
2023
Q3 		$29.4K Hold
1,574
– – ﹤0.01% 4266
2023
Q2 		$38.2K Hold
1,574
– – ﹤0.01% 4281
2023
Q1 		$34.4K Buy
1,574
+270
+21% +$10.3K ﹤0.01% 4349
2022
Q4 		$31.1K Hold
1,304
– – ﹤0.01% 4394
2022
Q3 		$36K Hold
1,304
– – ﹤0.01% 4410
2022
Q2 		$39K Sell
1,304
-6,369
-83% -$216K ﹤0.01% 4472
2022
Q1 		$412K Sell
7,673
-479
-6% -$38.4K ﹤0.01% 3815
2021
Q4 		$2.42M Buy
8,152
+220
+3% +$80.2K ﹤0.01% 3134
2021
Q3 		$3.08M Buy
7,932
+811
+11% +$321K ﹤0.01% 3045
2021
Q2 		$3.63M Buy
7,121
+2,575
+57% +$1.64M ﹤0.01% 3032
2021
Q1 		$2.58M Sell
4,546
-229
-5% -$152K ﹤0.01% 3114
2020
Q4 		$3.3M Buy
+4,775
New +$2.33M ﹤0.01% 2921

Other funds holding ALGS

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust's ALGS Position: Q1 2025 in Review

Northern Trust sold out of Aligos Therapeutics (ALGS) in Q1 2025, closing a stake of 5,157 shares — an estimated $205K sold.

Northern Trust first reported a position in ALGS in Q4 2020 and held it in 16 quarters. The position peaked at $3.63M in Q2 2021. 35 funds tracked by Wall St. Rank hold ALGS as of Q1 2025.

  • Northern Trust reported no remaining Aligos Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Northern Trust sold 5,157 Aligos Therapeutics shares in Q1 2025, an estimated $205K.
  • Northern Trust first reported a position in Aligos Therapeutics in Q4 2020 and held it in 16 quarters.
  • Northern Trust's Aligos Therapeutics position peaked at $3.63M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q1 2025.

Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.